Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Status:
Terminated

Trial end date:
2016-04-01

Target enrollment:

Participant gender:

Primary Objective: To assess the efficacy of SAR339658 Secondary Objective: To assess the safety of SAR339658

Phase 2

Sanofi